|

Navy Can Be Blamed for Mesothelioma Death

310188_Navy Ship small

A California Appeals Court says the U.S. Navy can legally be blamed for failing to protect one of its shipyard workers from the asbestos that eventually took his life.

Ulysses Collins died of mesothelioma, a cancer caused by asbestos, in 2005 at the age of 65.  Collins had spent 30 years working as a welder and pipefitter in various California Naval shipyards.  Collins and his family brought suit against 17 companies, including Plant Insulation, one of the major manufacturers of the asbestos insulation heavily used by the Navy.  A jury found in the Collins’ favor and awarded them $10 million, but the jury questioned why the Navy was not named as one of the entities at fault.

At the time, the Navy was found to be protected from liability in such cases under ‘sovereign immunity’, the concept that ‘the king (or the government) can do no wrong’. But Plant Insulation appealed the trial court’s decision arguing that sovereign immunity means only immunity from liability, not immunity from fault when failure of duty was at stake.  The Appeals court agreed and said that the Navy did have a duty to protect Collins and, because they did not do so, they could share in the blame for his mesothelioma.

The decision is significant because Navy veterans are among the most common victims of mesothelioma, a cancer that occurs in the lining around organs, especially the lungs.  Asbestos was used in a wide range of materials that went into Navy ships until the 1980’s and hundreds of thousands of veterans and shipyard workers were continually exposed to the toxic mineral.  According to evidence presented by Plant Insulation’s attorneys, the Navy did not warn Collins of the dangers of asbestos, train him in the proper techniques for working with it, or provide him with the necessary protective gear.

In their opinion, the appellate court said the jury should have the right to find fault with every party who contributed to the plaintiff’s injury, regardless of whether or not that party has immunity from being sued.  The higher the number of defendants found to be at fault, the less any single one of them has to pay out.  In the original trial, Plant Insulation was found to be 20% at fault and so was ordered to pay 20 percent of the $10 million damages awarded. The Collins case will now be remanded to the lower court for a new finding on the issue of fault.

Mesothelioma is an incurable and aggressive cancer that can take up to 50 years to develop.  About 2,000 Americans receive a diagnosis of mesothelioma every year.  Many of them, like Collins, worked in various construction trades.

Sources:

Collins vs. Plant Insulation Company, Court of Appeals opinion. June 15, 2010. Horvitz & Levy, LLP website.  Accessed June 20, 2010.
O’Brien, John. “Calif. Appeals court: Blaming Navy for asbestos is OK”, June 4, 2010. Legal News Online. Accessed June 20, 2010.
Adams, Barbara. “Court of Appeal Issues New Tort Decision on Fault Allocation”, June 8, 2010. Cal Biz Lit.

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…